Insecticides India Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/mrmttqiq0l9pnwtcgvvy6m9w.pdf

Key Takeaways


Top-Line Performance & Monsoon Impact

Rajesh Aggarwal: "Q2 was little challenging because of the adverse monsoon pattern because we have observed that there were heavy, untimely and un-required rains in many areas and then some of the areas were very dry."

Margin Headwinds & Recovery Path

Rajesh Aggarwal: "Number one is the international disturbance due to which the crop prices of the chemicals has changed a lot. There were acute shortages, there were shortages of containers due to which we were forced to buy some products at expensive prices actually and we could not get the same price from that market... the second impact was due to the currency because all the currencies across the world have depreciated in front of dollar which has given a very negative impact actually on the margins of the company."

New Product Pipeline & Strategy

Rajesh Aggarwal: "Shinwa, Hachiman and Torry they will be our top three products actually in the new cycle and my vision will be to cross 100 crores with each produced individually, but I can say at least all these three products put together will be crossing 300 crores for sure in the next fiscal itself."

Capacity Expansion & Backward Integration


Biologicals & New Subsidiary


Exports & International Markets

Rajesh Aggarwal: "We had initially kept the target of 200 crore means 200 crores of export sales, which I have revised 250 crores. I believe that I will still keep that target in mind and we will be working our international team will be working for this target..."

Guidance & Commitments

CommitmentSpecificsTimeline
Top-line growthVery strong double-digit growth in top line this fiscal; 20%+ growth in H2 FY23FY23
EBITDA margin recoveryEBITDA percentage to improve from H2; good recovery from Q1 of next fiscal; sustainable margin profile greater than 15%H2 FY23 onward; Q1 FY24
Shinwa salesCross ₹100 cr sales, become #1 productNext fiscal (FY24)
Top three new productsShinwa, Hachiman, Torry together cross ₹300 crNext fiscal (FY24)
Dahej plantFully operational, backward integration benefits beginJanuary 2023; next Kharif season
Rajasthan siteAvailable for formulation in Kharif seasonKharif season (2023)
Export salesAchieve revised target of ₹250 crFY23
Working capitalReduce total stocks in a big way by increasing sales and reducing purchasesQ3 FY23
New product launchesAbout one dozen products from R&D and Japanese partnerNext 6 to 8 months

Key Metrics

MetricQ2 FY23
Revenue from operations₹582 cr, up ~31% YoY from ₹444 cr
EBITDA₹69 cr, up ~6.68% YoY from ₹64 cr
PAT₹45 cr, up ~6.35% YoY from ₹42 cr
Price growth~6% to 7%, balance is volume growth
Currency impact on profitability~₹13 cr hit
H1 FY23 total revenue growth~25% increase
H2 FY23 revenue growth guidance20% plus growth expected
Export sales target₹250 cr, revised from initial ₹200 cr
Dahej project cost escalation~30% from pre-COVID estimates
Chopanki capacity increaseMore than 50% plus
Focus Maharatna sales contribution30% of sales
Maharatna brand sales contribution30% of brand sales
Chhattisgarh fraud outstanding~₹10 cr plus still in the market
Rajasthan new project total budget~₹150 cr